tiprankstipranks

William Denby Insider Profile

4 Followers
William Denby, Director at DMK Pharmaceuticals, holds 108.75K shares in DMK Pharmaceuticals (Ticker: DMKPQ), holds 0.00 shares in Santarus (Ticker: SNTS). Most recently, William Denby Bought ― shares of DMK Pharmaceuticals on May 28, 2019 for an estimated value of 9.94K.
tipranks
William Denby

William Denby
DMK Pharmaceuticals (DMKPQ)
Director

Ranked #80,902 out of 98,501 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-46.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5K
100.00%
A breakdown of William Denby's holdings

Insider Roles

DMK Pharmaceuticals
(DMKPQ)
Director
Roles that William Denby holds in companies

Most Profitable Insider Trade

Stock:
DMK Pharmaceuticals
(DMKPQ)
Rating:Informative Buy
Date:Sep 03, 2014 - Sep 03, 2015
Return:-25.80%
The most profitable trade made by William Denby

William Denby's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
DMK Pharmaceuticals
May 28, 2019
Director
Informative Buy
9.94K
$5.44K
SNTS
Santarus
Jan 06, 2014
Uninformative Buy
871.12K
List of latest transactions for each holding click on a transaction to see William Denby's performance on stock

William Denby insider profile FAQ

What is the percentage of profitable transactions made by William Denby?
The percentage of profitable transactions made by William Denby is 0%.
    What is the average return per transaction made by William Denby?
    The average return per transaction made by William Denby is -46.40%.
      What stocks does William Denby hold?
      William Denby holds: DMKPQ, SNTS stocks.
        What was William Denby’s latest transaction?
        William Denby latest transaction was an Informative Buy of $9.94K.
          What was William Denby's most profitable transaction?
          William Denby’s most profitable transaction was an Informative Buy of DMKPQ stock on September 3, 2014. The return on the trade was -25.80%.
            What is William Denby's role in DMK Pharmaceuticals?
            William Denby's role in DMK Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.